Quincke’s Edema (Angioedema)

What is Quincke's edema (angioedema)?

Quincke’s edema, more commonly called angioedema, is a sudden, localized swelling of the deeper layers of the skin and mucous membranes. The swelling usually involves the lips, eyelids, tongue, face, hands, feet, or the lining of the airway. Unlike a superficial rash, the fluid accumulates in the sub‑cutaneous (under‑the‑skin) or sub‑mucosal tissues, producing a puffy, often painful or burning feeling.

The term “Quincke’s edema” honors Heinrich Quincke, a German physician who first described the condition in the late 19th century. In modern practice the word “angioedema” is preferred because it describes the pathophysiology (vascular edema) rather than a single cause.

Most cases are self‑limited and resolve within a few hours to a few days, but some forms—especially those involving the airway—can be life‑threatening and require urgent treatment.

Common Causes

Angioedema is a symptom, not a disease. It can be triggered by a wide variety of mechanisms. The following are the most frequently encountered causes:

• Allergic reactions – foods (e.g., peanuts, shellfish), insect stings, latex, or medications such as antibiotics.
• Medication‑induced – especially ACE inhibitors (e.g., lisinopril, enalapril) and, less often, ARBs or NSAIDs.
• Hereditary angioedema (HAE) – a rare genetic deficiency of C1‑esterase inhibitor.
• Acquired C1‑esterase inhibitor deficiency – often associated with lymphoproliferative disorders or auto‑immune diseases.
• Idiopathic (unknown) angioedema – no clear trigger is identified despite thorough evaluation.
• Physical triggers – cold exposure, vibration, pressure, or sunlight (cold‑induced or cholinergic angioedema).
• Infections – viral (e.g., hepatitis C), bacterial sinusitis, or upper respiratory infections can precipitate swelling.
• Hormonal influences – estrogen‑containing oral contraceptives or hormone replacement therapy may exacerbate HAE.
• Autoimmune diseases – systemic lupus erythematosus, rheumatoid arthritis, or autoimmune thyroid disease.
• Rare causes – parasites (e.g., Loa loa), contact with certain chemicals, or malignant infiltration of the skin.

Associated Symptoms

Angioedema often co‑exists with other clinical features. Common accompanying signs include:

• Itching or a burning sensation at the site of swelling.
• Hives (urticaria) – raised, red welts that appear alongside deeper swelling.
• Difficulty swallowing (dysphagia) when the tongue or throat is involved.
• Voice changes or hoarseness due to laryngeal edema.
• Abdominal pain, nausea, vomiting, or diarrhea – especially in HAE where gastrointestinal wall swelling occurs.
• Shortness of breath or wheezing if airway edema develops.
• Feeling of tightness or fullness in the affected area.

When to See a Doctor

Most episodes of angioedema are mild and resolve on their own, but you should seek medical attention promptly if you notice any of the following:

• Swelling of the lips, tongue, or throat that makes speaking or swallowing difficult.
• Rapidly spreading swelling, especially around the eyes or face.
• Shortness of breath, wheezing, or a feeling of “tightness” in the chest.
• Sudden onset of severe abdominal pain, vomiting, or persistent diarrhea.
• Signs of an allergic reaction such as hives, flushing, or a rapid heartbeat.
• Recurrent episodes that occur more than once a month or interfere with daily activities.
• Any swelling that follows beginning a new medication (e.g., an ACE inhibitor).

When in doubt, err on the side of caution—especially if airway involvement is suspected.

Diagnosis

Diagnosing angioedema involves a combination of history taking, physical examination, and targeted laboratory tests.

Clinical Evaluation

• History – onset, duration, known triggers, medication list, family history of HAE, and associated symptoms.
• Physical exam – assessment of swelling distribution, presence of urticaria, and evaluation of airway patency.

Laboratory & Imaging Studies

• C4 complement level – low in hereditary or acquired C1‑esterase inhibitor deficiency.
• C1‑esterase inhibitor (C1‑INH) quantity and function – distinguishes between type I (quantitative) and type II (functional) HAE.
• Complete blood count (CBC) and metabolic panel to rule out infection or organ dysfunction.
• Allergy testing (skin prick or specific IgE) when an allergic trigger is suspected.
• Imaging (CT or MRI) of the neck only if airway obstruction is clinically concerning.

In the emergency setting, the primary goal is to assess airway safety; laboratory testing can be obtained once the patient is stabilized.

Treatment Options

Treatment depends on the underlying cause, severity, and whether the airway is compromised.

Acute Management

• Airway protection – If there is any sign of throat or laryngeal swelling, administer oxygen, prepare for possible intubation, and consider emergency cricothyrotomy.
• Antihistamines – Second‑generation H1 blockers (cetirizine, loratadine) for histamine‑mediated cases and H2 blockers (ranitidine, famotidine) as adjuncts.
• Corticosteroids – Prednisone or methylprednisolone can reduce inflammation, especially when the trigger is allergic.
• Epinephrine – Intramuscular 0.3 mg of 1:1000 solution for anaphylaxis‑type presentations (e.g., with urticaria, hypotension, or respiratory distress).
• Bradykinin‑targeted therapy – For hereditary or ACE‑inhibitor related angioedema:
  • Icademab (C1‑INH concentrate, e.g., Berinert, Cinryze)
  • Plasma‑derived kallikrein inhibitor (ecallantide)
  • Bradykinin B2‑receptor antagonist (icatibant)

Long‑Term Management

• Avoid known triggers – Identify foods, drugs, or environmental factors that precipitate attacks.
• Medication adjustments – Discontinue ACE inhibitors or switch to alternative antihypertensives if they are the culprit.
• Prophylactic therapy for HAE – Regular C1‑INH replacement, lanadelumab (a monoclonal antibody against plasma kallikrein), or berotralstat (oral kallikrein inhibitor).
• Rescue kits – Patients with frequent or severe episodes should carry self‑injectable C1‑INH or icatibant for early home treatment.
• Lifestyle modifications – Stress reduction, adequate hydration, and weight management can lessen attack frequency.

Home Care Measures

• Apply a cold compress (not ice directly) to reduce swelling.
• Elevate affected limbs to facilitate fluid drainage.
• Take over‑the‑counter antihistamines as directed, if previously effective.
• Maintain a diary of episodes, foods, drugs, and activities to help pinpoint triggers.
• Stay hydrated and avoid alcohol, which can exacerbate swelling.

Prevention Tips

While not all episodes can be prevented, the following strategies reduce risk:

• Medication review – Ask your physician to evaluate all prescriptions and over‑the‑counter drugs for potential angioedema‑inducing agents.
• Allergy testing – Confirm or rule out specific food or environmental allergies.
• Carry an emergency action plan – Include instructions for family, coworkers, and schools.
• Vaccinations – Stay current on influenza and COVID‑19 vaccines; infections can trigger attacks in susceptible individuals.
• Stress management – Techniques such as yoga, meditation, or cognitive‑behavioral therapy have been shown to lower attack frequency in HAE patients.
• Regular follow‑up – Especially for hereditary or acquired C1‑INH deficiency, routine labs guide prophylactic dosing.

Emergency Warning Signs

Key Take‑aways

Quincke’s edema (angioedema) is a potentially serious swelling of deep skin layers that can arise from allergies, medications, hereditary factors, or unknown causes. Prompt recognition of airway involvement, appropriate emergency treatment, and targeted long‑term strategies are essential to reduce morbidity and mortality. If you experience unexplained swelling—especially of the face, lips, tongue, or throat—seek medical evaluation promptly.

References

• Mayo Clinic. “Angioedema.” https://www.mayoclinic.org.
• Cleveland Clinic. “Angioedema: Symptoms, Causes, and Treatment.” https://my.clevelandclinic.org.
• National Institute of Allergy and Infectious Diseases (NIAID). “Hereditary Angioedema.” https://www.niaid.nih.gov.
• World Health Organization. “Anaphylaxis and Angioedema.” WHO Guidelines, 2022.
• U.S. Centers for Disease Control and Prevention. “Allergic Reactions & Anaphylaxis.” https://www.cdc.gov.
• Schulman, A., et al. “Management of Acute Angioedema.” *Journal of Allergy and Clinical Immunology*, 2021;147(5):1525‑1534.